Study identifies key risk factors driving MASLD across populations
Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 32% of the US adult population. The…
Palmatine improved fatty liver markers in a preclinical type 2 diabetes study
A new preclinical study suggests that palmatine may ease diabetes-linked fatty liver disease by targeting inflammation, oxidative stress,…